Are you a member of the press? Visit Our Press Kit
Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States
CVRx® Appoints New Chief Marketing Officer and Vice President of European Sales and Marketing
Does Neuromodulation Using Baroreflex Activation Therapy (BAT) have Potential Application in HFpEF?